QQ
微信
| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| Suptavumab | Suptavumab | 1629615-23-1 |
| Lupartumab | Lupartumab | 1640971-88-5 |
| Rosmantuzumab | Rosmantuzumab | 1684393-04-1 |
| Emapalumab | 依玛鲁单抗 | 1709815-23-5 |
| Azintuxizumab | Azintuxizumab | 1826819-57-1 |
| Gilvetmab | Gilvetmab | 1808081-43-7 |
| Ianalumab | Ianalumab | 1929549-92-7 |
| Atidortoxumab | 阿度尤单抗 | 1939108-95-8 |
| Relatlimab | Relatlimab | 1673516-98-7 |
| Utomilumab | 乌托鲁单抗 | 1417318-27-4 |
| Diridavumab | Diridavumab | 1393659-46-5 |
| Elotuzumab | 埃罗妥珠单抗 | 915296-00-3 |
| Donanemab | DONANEMAB (多奈单抗 ) | 1931944-80-7 |
| Bemarituzumab | 贝马里妥珠单抗 | 1952272-74-0 |
| Plozalizumab | Plozalizumab | 1610761-46-0 |
| Exbivirumab | EXBIVIRUMAB ( 艾韦单抗 ) | 569658-80-6 |
| Rovalpituzumab Tesirine | Rovalpituzumab Tesirine | 1613313-09-9 |
| Lulizumab Pegol | Lulizumab Pegol | 1421830-13-8 |
| Quetmolimab | QUETMOLIMAB (奎莫利单抗 ) | 2084037-83-0 |
| Leronlimab | 乐利单抗 | 674782-26-4 |
